Human Genome Project Information. Click to return to home page.

Sponsored by the U.S. Department of Energy Human Genome Program

Human Genome News Archive Edition

Vol.12, Nos.1-2   February 2002

 

Available in PDF
 
In this issue...

In the News

Special Meeting Report

Web, Publications, Resources

Funding Information

Meeting Calendars & Acronyms

  • Genome and Biotechnology Meetings
  • Training Courses and Workshops
  • Acronyms

Spinach Protein Offers New Hope for the Blind

This article, written by Carolyn Krause, appeared in the ORNL Review 34 (2), 14 (2001). It has been adapted for use in HGN.

Spinach may make Popeye the Sailor Man strong, but a protein from spinach may someday strengthen the vision of people who can barely see. Researchers at Oak Ridge National Laboratory (ORNL) and the University of Southern California (USC) are investigating whether this chlorophyll-containing protein might be useful in restoring sight by replacing a key light-receiving} part of the human eye that has lost its ability to function. People who suffer from age-related macular degeneration (AMD) or retinitis pigmentosa (RP), diseases that are the leading causes of blindness worldwide, may find hope in this research.

Although the neural wiring from eye to brain is intact in patients with these diseases, their eyes lack photoreceptor activity. A team led by Elias Greenbaum at ORNL is replacing these inactive photoreceptors with a spinach protein that gives off a small electrical voltage after capturing the energy of incoming photons of light. Called Photosystem I, or PSI (pronounced PS One), the main function of this photosynthetic reaction center protein is to perform photosynthesis, using the energy of the sun to make plant tissue.

Mark Humayun of the Doheny Retina Institute at USC (www.usc.edu/hsc/doheny/) and his research team showed that if retinal tissue is stimulated electrically using pinhead-sized electrodes implanted in the eye, many patients can perceive image patterns that mimic the effects of stimulation by light. Teaming with Humayun, Greenbaum suggested the possibility of using PSI proteins to restore photoreceptor activity. ORNL experiments showed that PSI proteins can capture photon energy and generate electric voltages (about 1 V).

This project, Greenbaum stated, is based on recent original discoveries. “Using the technique of Kelvin force microscopy, we have performed the first measurements of voltages induced by photons of light from single photosynthetic reaction centers. This work was published in 2000 in an issue of the Journal of Physical Chemistry B (http://pubs.acs.org/journals/jpcbfk/). The measured photovoltage values, typically 1 V or more, are sufficiently large to trigger a neural response. We are inserting purified PSI reaction centers into retinal cells to determine whether they will restore photo-receptor function in persons who have AMD or RP. Once we demonstrate that this is possible, USC researchers will test the technique in the laboratory, and, if feasible, later in humans in clinical trials.”

In recent research, the collaborators showed that PSI reaction centers could be incorporated into a liposome, an artificial membrane made of lipids that mimics the composition of a membrane of a living cell. They also demonstrated that PSI can be functional inside a liposomethat is, it produces the experimental equivalent of a voltage when light is shined on it. A liposome probably will be used to deliver PSI to a retinal cell.

Also, in work published in Photochemistry and Photobiology in June 2001, the collaborators showed that isolated PSI reaction centers can photo-evolve hydrogen, indicating that PSI maintains its voltage-generating properties under conditions of current flow.


FYI: Currently, in the United States, degeneration of the retina—the light-sensitive layer of tissue at the back of the eye—has left 20,000 people totally blind and 500,000 people visually impaired. RP is an inherited condition of the retina in which specific photoreceptor cells, called rods, degenerate. The loss of function of these rod cells diminishes a persons ability to see in dim light and gradually can reduce peripheral vision as well.

AMD is a disease that affects the center of vision; people rarely go blind from the disease but may have great difficulty reading, driving, and performing other activities that require fine, sharp, straight-ahead vision. AMD affects the macula, the center of the retina. When light is focused onto the macula, millions of cells change the light into an electrical current for the benefit of the neural wiring that tells the brain what the eye is seeing.

Return to Top of Page

Return to Top


The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v12n1-2).

Human Genome Project 1990–2003

The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.

Human Genome News

Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.